32 related articles for article (PubMed ID: 5329155)
1. Could protein kinase inhibitors become a next generation pharmacotherapy for non-Hodgkin's lymphoma?
Cohen M; Graf SA
Expert Opin Pharmacother; 2024 Apr; 25(6):637-640. PubMed ID: 38726844
[No Abstract] [Full Text] [Related]
2. [USE OF EMBITOL, BENZOTEF AND PREPARATION A-4 IN LYMPHOGRANULOMATOSIS IN CHILDREN].
KOLNER RI; ZELENETSKY I
Pediatr Akus Ginekol; 1963; 6():14-7. PubMed ID: 14113597
[No Abstract] [Full Text] [Related]
3. Amitriptyline and excessive appetite.
Brown JH
Can Med Assoc J; 1967 Nov; 97(22):1361. PubMed ID: 6061605
[No Abstract] [Full Text] [Related]
4. Manic reaction associated with procarbazine hydrochloride therapy of Hodgkin's disease.
Mann AM; Hutchison JL
Can Med Assoc J; 1967 Nov; 97(22):1350-3. PubMed ID: 6061601
[No Abstract] [Full Text] [Related]
5. Cancer chemotherapy--the first twenty-five years.
Scott RB
Br Med J; 1970 Oct; 4(5730):259-65. PubMed ID: 4319950
[No Abstract] [Full Text] [Related]
6. [Long term treatment of advanced vinblastine-resistant lymphogranulomatosis with ibenzmethyzin (Natulan)].
Schulz E; Cissée H; Hausmann K
Klin Wochenschr; 1970 Nov; 48(21):1291-9. PubMed ID: 4103872
[No Abstract] [Full Text] [Related]
7. N-methyl antitumour agents. A distinct class of anticancer drugs?
Newell D; Gescher A; Harland S; Ross D; Rutty C
Cancer Chemother Pharmacol; 1987; 19(2):91-102. PubMed ID: 3552281
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
Cridland MD
Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
[No Abstract] [Full Text] [Related]
9. [Natulan (experimental and clinical data on its antitumor effect)].
Brodskaia NA
Vopr Onkol; 1972; 18(11):101-9. PubMed ID: 4566561
[No Abstract] [Full Text] [Related]
10. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Hansen MM; Hertz H; Videaek A
Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
[No Abstract] [Full Text] [Related]
11. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
Spies SK; Snyman HW
S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
[No Abstract] [Full Text] [Related]
12. Chemotherapy of the lymphomas.
Lacher MJ
Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
[No Abstract] [Full Text] [Related]
13. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
Holsti LR; Hjelt AL
Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
[No Abstract] [Full Text] [Related]
14. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Danieli G
G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
[No Abstract] [Full Text] [Related]
15. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
Nissen I; Poulsen EH
Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
